ey0015.10-19 | Prevention | ESPEYB15
NA Lund-Blix , S Dydensborg Sander , K Størdal , AM Nybo Andersen , KS Rønningen , G Joner , T Skrivarhaug , PR Njølstad , S Husby , LC Stene
ey0015.10-20 | Prevention | ESPEYB15
Writing Group for the TRIGR Study Group , M Knip , HK Åkerblom , E Al Taji , D Becker , J Bruining , L Castano , T Danne , C de Beaufort , HM Dosch , J Dupre , WD Fraser , N Howard , J Ilonen , D Konrad , O Kordonouri , JP Krischer , ML Lawson , J Ludvigsson , L Madacsy , JL Mahon , A Ormisson , JP Palmer , P Pozzilli , E Savilahti , M Serrano-Rios , M Songini , S Taback , Vaarala , NH White , SM Virtanen , R Wasikowa
ey0015.10-21 | Prevention | ESPEYB15
CJ Simeonovic , SK Popp , LM Starrs , DJ Brown , AF Ziolkowski , B Ludwig , SR Bornstein , JD Wilson , A Pugliese , TWH Kay , HE Thomas , T Loudovaris , FJ Choong , C Freeman , CR Parish
ey0015.10-22 | Prevention | ESPEYB15
Writing Committee for the T1DM TrialNet Oral Insulin Study Group , JP Krischer , DA Schatz , B Bundy , JS Skyler , CJ Greenbaum